BNY Mellon Global Equity Income Fund EUR W AccRegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 1.4 | 16.4 | 8.1 | 4.5 | 2.0 | |
+/-Cat | -0.5 | -1.8 | 8.8 | -2.8 | -1.0 | |
+/-B’mrk | - | -3.9 | 1.3 | -0.2 | -0.7 | |
Category: Global Equity Income | ||||||
Category Benchmark: Morningstar Gbl High Div Yl... |
Key Stats | ||
NAV 27/03/2024 | EUR 2.95 | |
Day Change | 0.08% | |
Morningstar Category™ | Global Equity Income | |
ISIN | IE00B90JKR63 | |
Fund Size (Mil) 29/02/2024 | USD 441.73 | |
Share Class Size (Mil) 27/03/2024 | EUR 71.42 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 24/11/2023 | 0.88% |
Investment Objective: BNY Mellon Global Equity Income Fund EUR W Acc |
The objective of the Sub-Fund is to aim to generate annual distributions and to achieve long-term capital growth by investing predominantly in equity and equity-related global securities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jonathan Bell 01/04/2020 | ||
James Lydotes 10/02/2023 | ||
Click here to see others | ||
Inception Date 05/12/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE World TR USD | Morningstar Gbl High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BNY Mellon Global Equity Income Fund EUR W Acc | 31/01/2024 |
|
|
Top 5 Holdings | Sector | % |
Sanofi SA | Healthcare | 3.46 |
CME Group Inc Class A | Financial Services | 3.32 |
Medtronic PLC | Healthcare | 3.17 |
AbbVie Inc | Healthcare | 2.85 |
Publicis Groupe SA | Communication Services | 2.81 |
Increase Decrease New since last portfolio | ||
BNY Mellon Global Equity Income Fund EUR W Acc |